An Open-Label Extension Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00007248/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the long-term safety of every other week dosing of
Gene-Activated® human glucocerebrosidase (GA-GCB, velaglucerase alfa) intravenously in
patients with type 1 Gaucher disease.
提供机构：
Vivli
创建时间：
2021-07-01
